Instylla Logo

Materializing Solutions

Instylla delivers next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.

LatesT news

Instylla Announces Enrollment of Initial Patient in the Prospective Multicenter “HALT” Study

January 10, 2023

Pivotal study to evaluate Embrace™ Hydrogel Embolic System for the embolization of arterial bleeds in the peripheral vasculature BEDFORD, Mass., – January 10, 2023 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the enrollment of the first patient in the HALT Study¹ for the treatment of […]

Read More